<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03897387</url>
  </required_header>
  <id_info>
    <org_study_id>MUSA-H-VDM-001</org_study_id>
    <nct_id>NCT03897387</nct_id>
  </id_info>
  <brief_title>Post Market, Retrospective Study to Evaluate Patients Implanted With Medacta Versafit Cup DM ™️ 2 Years Post-op</brief_title>
  <official_title>A Post-market, Multi-center, Retrospective Study to Identify Clinical Outcomes and Complications Data From Patients Implanted With the Medacta Versafit Cup DM Prosthesis Who Are at Least Two Years Post Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta USA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a post-market, retrospective with one prospective visit, multi- center study,
      designed to assess the clinical outcomes, surgical details including Anterior or Posterior
      surgical approach, and collect all complication data of Medacta Versafit Cup DM used for
      primary or revision total hip arthroplasty at minimum two year post- operatively.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dislocation rate of Medacta Versafit Cup DM</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Determine radiographic analysis of component position in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant position fixation and wear</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Determine by radiographic analysis by measuring Radio Lucent lines in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Limb length</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Determined by radiographic analysis by measuring in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Satisfaction and outcome score</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Determined by the Hip Disability and Osteoarthritis Outcome Score (HOOS) likert scale score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient questionnaire Forgotten Joint Score (FJS)</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Assessment of awareness of the artificial joint in every day life using the FJS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient questionnaire Harris Hip Score (HHS)</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Assessment of the improvement of clinical outcomes following total hip replacement using the Harris Hip Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient questionnaire Likert Scale Score</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Assessment of patient satisfaction using the Likert Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait analysis</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Assessment of patient limp, use of assistive device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Assessment of contracture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant survivorship</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Determine by radiographic analysis of bone fracture, implant fracture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Approach</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Chart review to determine anterior or posterior approach</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant demographics</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Chart review to determine type of bearing in Versafit DM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Minimum 2 years post surgery</time_frame>
    <description>Chart review to determine adverse events and serious adverse events</description>
  </secondary_outcome>
  <enrollment type="Anticipated">528</enrollment>
  <condition>Hip Arthritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Up to a total of 528 qualified patients who have undergone primary or revision Total Hip
        Arthroplasty (THA) will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects age 18 years and above at the time of consent

          2. Able to understand the requirements of the study, provide a written informed consent
             and comply with the study protocol. Written informed consent must be obtained prior to
             any study procedure. 3 Patients must be willing to comply with the prospective visit
             schedule.

        4. Patient underwent a primary or revision total hip replacement for any etiology
        (osteoarthritis, avascular necrosis, inflammatory arthritis, post- traumatic arthritis, hip
        fracture, failed prior procedures, etc.). 5. Patients must have received a Medacta Versafit
        Cup DM component 6. Patient must have adequate pre-operative and post-operative radiographs
        7. Patients must be at minimum 2 year (24 months) post-treatment 8. The operation was
        performed by the investigator.

        Exclusion Criteria:

          1. History of alcoholism

          2. Currently on chemotherapy or radiation therapy

          3. Habitual use of narcotic pain medications prior to surgery or after surgery for
             reasons other than hip pain

          4. History of a metabolic disorder such as Gout affecting the skeletal system other than
             osteoarthritis or osteoporosis

          5. History of chronic pain issues for reasons other than hip pain

          6. Women that are pregnant

          7. Patients who underwent Total Hip Arthroplasty (THA) using standard polyethylene
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mukesh Ahuja, CPI, MBBS, MS</last_name>
    <phone>312-548-9968</phone>
    <email>mahuja@medacta.us.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peak Orthopedics</name>
      <address>
        <city>Lone Tree</city>
        <state>Colorado</state>
        <zip>80124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Robert Greenhow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Illinois Bone and Joint Institute</name>
      <address>
        <city>Libertyville</city>
        <state>Illinois</state>
        <zip>60048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Thadani, MD</last_name>
      <phone>847-247-4000</phone>
      <email>pthadani@ibji.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Orthopedics</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78759</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyler Goldberg, MD</last_name>
      <phone>512-439-1001</phone>
      <email>tgoldberg@texasorthopedics.com</email>
    </contact>
    <investigator>
      <last_name>Tyler Goldberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2019</study_first_posted>
  <last_update_submitted>March 28, 2019</last_update_submitted>
  <last_update_submitted_qc>March 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

